Neuroglia in neurodegeneration

Brain Research Reviews

Volumn 63, Issue 1-2, 2010, Pages 189-211

  Heneka, Michael T ^a   Rodríguez, José J ^b,e   Verkhratsky, Alexei ^c,d,e  

^a Klinische Neurowissenschaften   (Germany)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Astrocyte; Dementia; Glia; Microglia; Neurodegeneration; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; AMYLOID BETA PROTEIN; CELECOXIB; CHEMOKINE RECEPTOR CXCR4; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; EXCITATORY AMINO ACID TRANSPORTER; LEVODOPA; MINOCYCLINE; NIMESULIDE; PIOGLITAZONE; PURINERGIC P2X RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; COMPLEMENT CLASSICAL PATHWAY; DEMENTIA; DISEASE COURSE; DRUG MECHANISM; GLIA; GLIA CELL; HOMEOSTASIS; HUMAN; MICROGLIA; NERVE CELL; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; WERNICKE ENCEPHALOPATHY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROGLIA;

EID: 77952428961     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.11.004     Document Type: Review

References (319)

1. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 2009, 32:19-29.
2. Abramov A.Y., Canevari L., Duchen M.R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 2003, 23:5088-5095.
3. Abramov A.Y., Canevari L., Duchen M.R. β-Amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 2004, 24:565-575.
4. Agulhon C., Petravicz J., McMullen A.B., Sweger E.J., Minton S.K., Taves S.R., Casper K.B., Fiacco T.A., McCarthy K.D. What is the role of astrocyte calcium in neurophysiology?. Neuron 2008, 59:932-946.
5. Akiguchi I., Tomimoto H., Suenaga T., Wakita H., Budka H. Alterations in glia and axons in the brains of Binswanger's disease patients. Stroke 1997, 28:1423-1429.
6. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
7. Almer G., Vukosavic S., Romero N., Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 1999, 72:2415-2425.
8. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A.P., Chen C., Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 2001, 49:176-185.
9. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., Peschle C. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1-β and tumor-necrosis-factor-α. J. Immunol. 1992, 149:2358-2366.
10. Alzheimer A. Beiträge zur Kenntnis der pathologischen Neuroglia und ihrer Beziehungen zu den Abbauvorgängen im Nervengewebe. Histologische und histopathologische Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten 1910, 401-562. Gustav Fischer, Jena. F. Nissl, A. Alzheimer (Eds.).
11. Andriezen W.L. The neuroglia elements of the brain. Brit. Med. J. 1893, 2:227-230.
12. Angulo M.C., Le Meur K., Kozlov A.S., Charpak S., Audinat E. GABA, a forgotten gliotransmitter. Prog. Neurobiol. 2008, 86:297-303.
13. Antel J., Arnold D. Multiple sclerosis. Neuroglia 2005, 489-500. Oxford University Press, Oxford. H. Kettenmann, B. Ransom (Eds.).
14. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999, 22:208-215.
15. Bach J.H., Chae H.S., Rah J.C., Lee M.W., Park C.H., Choi S.H., Choi J.K., Lee S.H., Kim Y.S., Kim K.Y., Lee W.B., Suh Y.H., Kim S.S. C-terminal fragment of amyloid precursor protein induces astrocytosis. J. Neurochem. 2001, 78:109-120.
16. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Estevez A.G., Beckman J.S. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 2004, 47:263-274.
17. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881.
18. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., Fiebich B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 1997, 243:726-731.
19. Beers D.R., Henkel J.S., Xiao Q., Zhao W.H., Wang J.H., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16021-16026.
20. Beglopoulos V., Sun X., Saura C.A., Lemere C.A., Kim R.D., Shen J. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol. Chem. 2004, 279:46907-46914.
21. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118:103-113.
22. Benveniste E.N., Nguyen V.T., O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 2001, 39:381-391.
23. Bergles D.E., Roberts J.D., Somogyi P., Jahr C.E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000, 405:187-191.
24. Berry M., Hubbard P., Butt A.M. Cytology and lineage of NG2-positive glia. J. Neurocytol. 2002, 31:457-467.
25. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391:281-285.
26. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
27. Bezzi P., Gundersen V., Galbete J.L., Seifert G., Steinhauser C., Pilati E., Volterra A. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat. Neurosci. 2004, 7:613-620.
28. Biber K., Neumann H., Inoue K., Boddeke H.W. Neuronal 'on' and 'off' signals control microglia. Trends Neurosci. 2007, 30:596-602.
29. Bilak M., Wu L., Wang Q., Haughey N., Conant K., St Hillaire C., Andreasson K. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 2004, 56:240-248.
30. Blasko I., Marx F., Steiner E., Hartmann T., Grubeck-Loebenstein B. TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999, 13:63-68.
31. Blumenthal I. Periventricular leucomalacia: a review. Eur. J. Pediatr. 2004, 163:435-442.
32. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
33. Bolmont T., Haiss F., Eicke D., Radde R., Mathis C.A., Klunk W.E., Kohsaka S., Jucker M., Calhoun M.E. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 2008, 28:4283-4292.
34. Botto M. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp. Clin. Immunogenet. 1998, 15:231-234.
35. Braida D., Sacerdote P., Panerai A.E., Bianchi M., Aloisi A.M., Iosue S., Sala M. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav. Brain Res. 2004, 153:423-429.
36. Breidert T., Callebert J., Heneka M.T., Landreth G., Launay J.M., Hirsch E.C. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J. Neurochem. 2002, 82:615-624.
37. Broe M., Kril J., Halliday G.M. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 2004, 127:2214-2220.
38. Bruzzone R., Giaume C. Connexins and information transfer through glia. Adv. Exp. Med. Biol. 1999, 468:321-337.
39. Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 2002, 22:183-192.
40. Bushong E.A., Martone M.E., Ellisman M.H. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int. J. Dev. Neurosci. 2004, 22:73-86.
41. Butovsky O., Talpalar A.E., Ben Yaakov K., Schwartz M. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Mol. Cell Neurosci. 2005, 29:381-393.
42. Butt A.M. Structure and function of oligodendrocytes. Neuroglia 2005, 36-47. Oxford University Press, Oxford. H. Kettenmann, B. Ransom (Eds.).
43. Butt A.M., Hamilton N., Hubbard P., Pugh M., Ibrahim M. Synantocytes: the fifth element. J. Anat. 2005, 207:695-706.
44. Castell J.V., Gomez-Lechon M.J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P.C. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989, 242:237-239.
45. Charcot J.M. Amyotrophic lateral sclerosis: symptomatology. Lectures on diseases of the nervous system 1881, 192-204. New Sydenham Society, London.
46. Charcot J.M., Joffroy A. Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et de faisceaux anterolateraux de la moelle epiniere. Arch. Physiol. Norm. Pathol. 1869, 1:354-367.
47. Chen K., Iribarren P., Hu J., Chen J., Gong W., Cho E.H., Lockett S., Dunlop N.M., Wang J.M. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 2006, 281:3651-3659.
48. Chittajallu R., Aguirre A., Gallo V. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J. Physiol. 2004, 561:109-122.
49. Chong Y. Effect of a carboxy-terminal fragment of the Alzheimer's amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells. Life Sci. 1997, 61:2323-2333.
50. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., Lawler J., Mosher D.F., Bornstein P., Barres B.A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
51. Cohen-Gadol A.A., Pan J.W., Kim J.H., Spencer D.D., Hetherington H.H. Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysis. J. Neurosurg. 2004, 101:613-620.
52. Coles J.A., Orkand R.K. Modification of potassium movement through the retina of the drone (Apis mellifera male) by glial uptake. J. Physiol. 1983, 340:157-174.
53. Combs C.K., Bates P., Karlo J.C., Landreth G.E. Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem. Int. 2001, 39:449-457.
54. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21:1179-1188.
55. Cornell Bell A.H., Finkbeiner S.M., Cooper M.S., Smith S.J. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 1990, 247:470-473.
56. Dabir D.V., Trojanowski J.Q., Richter-Landsberg C., Lee V.M., Forman M.S. Expression of the small heat-shock protein αB-crystallin in tauopathies with glial pathology. Am. J. Pathol. 2004, 164:155-166.
57. Danbolt N.C. Glutamate uptake. Progr. Neurobiol. 2001, 65:1-105.
58. D'Andrea M.R., Cole G.M., Ard M.D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging 2004, 25:675-683.
59. Dani J.W., Chernjavsky A., Smith S.J. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 1992, 8:429-440.
60. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
61. DeGiorgio L.A., Shimizu Y., Chun H.S., Cho B.P., Sugama S., Joh T.H., Volpe B.T. APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy. Glia 2002, 38:174-178.
62. Dehmer T., Lindenau J., Haid S., Dichgans J., Schulz J.B. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 2000, 74:2213-2216.
63. Dehmer T., Heneka M.T., Sastre M., Dichgans J., Schulz J.B. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J. Neurochem. 2004, 88:494-501.
64. Deitmer J.W., Verkhratsky A.J., Lohr C. Calcium signalling in glial cells. Cell. Calc. 1998, 24:405-416.
65. Dermietzel R., Gao Y., Scemes E., Vieira D., Urban M., Kremer M., Bennett M.V., Spray D.C. Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res. Brain Res. Rev. 2000, 32:45-56.
66. Deshpande M., Zheng J., Borgmann K., Persidsky R., Wu L., Schellpeper C., Ghorpade A. Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox. Res. 2005, 7:183-192.
67. DeWitt D.A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 1998, 149:329-340.
68. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83.
69. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007, 10:608-614.
70. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 2002, 52:771-778.
71. 7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 2003, 23:1320-1328.
72. + homeostasis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1193-1198.
73. Eikelenboom P., van Gool W.A. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J. Neural. Transm. 2004, 111:281-294.
74. Eikelenboom P., Zhan S.S., van Gool W.A., Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 1994, 15:447-450.
75. Ercolini A.M., Miller S.D. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 2006, 176:3293-3298.
76. Fellin T., Pascual O., Gobbo S., Pozzan T., Haydon P.G., Carmignoto G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004, 43:729-743.
77. Fellin T., Gomez-Gonzalo M., Gobbo S., Carmignoto G., Haydon P.G. Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices. J. Neurosci. 2006, 26:9312-9322.
78. Fetler L., Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science 2005, 309:392-393.
79. Floden A.M., Combs C.K. β-Amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J. Neurosci. 2006, 26:4644-4648.
80. Forman M.S., Lal D., Zhang B., Dabir D.V., Swanson E., Lee V.M., Trojanowski J.Q. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J. Neurosci. 2005, 25:3539-3550.
81. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 1998, 152:307-317.
82. Frei K., Nohava K., Malipiero U.V., Schwerdel C., Fontana A. Production of macrophage colony-stimulating factor by astrocytes and brain macrophages. J. Neuroimmunol. 1992, 40:189-196.
83. Gadea A., Lopez-Colome A.M. Glial transporters for glutamate, glycine and GABA I. Glutamate transporters. J. Neurosci. Res. 2001, 63:453-460.
84. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 2007, 14:1324-1335.
85. Giaume C., Maravall M., Welker E., Bonvento G. The barrel cortex as a model to study dynamic neuroglial interaction. Neuroscientist 2009, 15:351-366.
86. Godoy M.C.P., Tarelli R., Ferrari C.C., Sarchi M.I.S., Pitossi F.J. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008, 131:1880-1894.
87. Golgi C. Opera Omnia 1903, Milano, Hoepli.
88. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 2000, 20:660-665.
89. Grammas P., Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 2001, 22:837-842.
90. Griffin W.S.T. IL-1 and the cytokine cycle in Alzheimer's disease. J. Neurochem. 2000, 74:S52.
91. Gurnett C.A., Landt M., Wong M. Analysis of cerebrospinal fluid glial fibrillary acidic protein after seizures in children. Epilepsia 2003, 44:1455-1458.
92. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
93. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13:54-63.
94. Halassa M.M., Fellin T., Takano H., Dong J.H., Haydon P.G. Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 2007, 27:6473-6477.
95. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
96. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
97. Hartlage-Rubsamen M., Zeitschel U., Apelt J., Gartner U., Franke H., Stahl T., Gunther A., Schliebs R., Penkowa M., Bigl V., Rossner S. Astrocytic expression of the Alzheimer's disease β-secretase (BACE1) is stimulus-dependent. Glia 2003, 41:169-179.
98. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006, 86:1009-1031.
99. Hazell A.S. Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy. Neurochem. Int. 2009, 55:129-135.
100. Hazell A.S., Sheedy D., Oanea R., Aghourian M., Sun S., Jung J.Y., Wang D., Wang C. Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia 2009, 58:148-156.
101. Heneka M.T., Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 2001, 114:8-18.
102. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184:69-91.
103. Heneka M.T., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D.L., Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:906-916.
104. Heneka M.T., Sastre M., Dumitrescu-Ozimek L., Dewachter I., Walter J., Klockgether T., Van Leuven F. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflam. 2005, 2:22.
105. 1-42 levels in APPV717I transgenic mice. Brain 2005, 128:1442-1453.
106. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C., West M., Williamson K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2002, 82:365-374.
107. Hensley K., Fedynyshyn J., Ferrell S., Floyd R.A., Gordon B., Grammas P., Hamdheydari L., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., West S., Williamson K.S. Message and protein-level elevation of tumor necrosis factor α (TNF α) and TNF α-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 2003, 14:74-80.
108. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1500-1505.
109. Horuk R., Martin A.W., Wang Z.X., Schweitzer L., Gerassimides A., Guo H.H., Lu Z.H., Hesselgesser J., Perez H.D., Kim J., Parker J., Hadley T.J., Peiper S.C. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 1997, 158:2882-2890.
110. Houades V., Koulakoff A., Ezan P., Seif I., Giaume C. Gap junction-mediated astrocytic networks in the mouse barrel cortex. J. Neurosci. 2008, 28:5207-5217.
111. Iadecola C., Nedergaard M. Glial regulation of the cerebral microvasculature. Nat. Neurosci. 2007, 10:1369-1376.
112. 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. FASEB J. 2005, 19:2032-2034.
113. Jabs R., Matthias K., Grote A., Grauer M., Seifert G., Steinhauser C. Lack of P2X receptor mediated currents in astrocytes and GluR type glial cells of the hippocampal CA1 region. Glia 2007, 55:1648-1655.
114. Jabs R., Seifert G., Steinhauser C. Astrocytic function and its alteration in the epileptic brain. Epilepsia 2008, 49(Suppl. 2):3-12.
115. Jang H., Boltz D., Sturm-Ramirez K., Shepherd K.R., Jiao Y., Webster R., Smeyne R.J. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14063-14068.
116. Jessen K.R., Mirsky R. Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 2008, 56:1552-1565.
117. Jiang C., Ting A.T., Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
118. Johansson A., Engler H., Blomquist G., Scott B., Wall A., Aquilonius S.M., Langstrom B., Askmark H. Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET. J. Neurol. Sci. 2007, 255:17-22.
119. Jourdain P., Bergersen L.H., Bhaukaurally K., Bezzi P., Santello M., Domercq M., Matute C., Tonello F., Gundersen V., Volterra A. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 2007, 10:331-339.
120. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat. Genet. 1995, 10:486-488.
121. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., Nedergaard M. Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 2008, 28:4702-4711.
122. Karram K., Goebbels S., Schwab M., Jennissen K., Seifert G., Steinhauser C., Nave K.A., Trotter J. NG2-expressing cells in the nervous system revealed by the NG2-EYFP-knockin mouse. Genesis 2008, 46:743-757.
123. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
124. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 1999, 155:995-1004.
125. Kersaitis C., Halliday G.M., Kril J.J. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol. 2004, 108:515-523.
126. Kershman J. Genesis of microglia in the human brain. Arch. Neurol. Psychiatr. 1939, 41:24-50.
127. Neuroglia 2005, Oxford, OUP. H. Kettenmann, B.R. Ransom (Eds.).
128. Kettenmann H., Verkhratsky A. Neuroglia: the 150 years after. Trends Neurosci. 2008, 31:653-659.
129. Kiaei M., Kipiani K., Chen J.Y., Calingasan N.Y., Beal M.F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2005, 191:331-336.
130. Kim S., Cho S.H., Kim K.Y., Shin K.Y., Kim H.S., Park C.H., Chang K.A., Lee S.H., Cho D., Suh Y.H. α-Synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP 4. J. Neurochem. 2009, 109:1483-1496.
131. 2+ signaling in Bergmann glial cells in situ. FASEB J. 1997, 11:566-572.
132. Kirischuk S., Kettenmann H., Verkhratsky A. Membrane currents and cytoplasmic sodium transients generated by glutamate transport in Bergmann glial cells. Pflugers. Arch. 2007, 454:245-252.
133. Kofuji P., Newman E.A. Potassium buffering in the central nervous system. Neuroscience 2004, 129:1045-1056.
134. Kölliker A. Handbuch der Gewebelehre des Menschen 1889, Leipzig, Wilhelm Engelmann.
135. Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 1999, 9:663-679.
136. Kozlov A.S., Angulo M.C., Audinat E., Charpak S. Target cell-specific modulation of neuronal activity by astrocytes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10058-10063.
137. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
138. Kriz J., Nguyen M.D., Julien J.P. Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis. Neurobiol. Dis. 2002, 10:268-278.
139. Kuchibhotla K.V., Lattarulo C.R., Hyman B.T., Bacskai B.J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009, 323:1211-1215.
140. Kunst C.B. Complex genetics of amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75:933-947.
141. Lalo U., Pankratov Y., Kirchhoff F., North R.A., Verkhratsky A. NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. J. Neurosci. 2006, 26:2673-2683.
142. 5 subunits form the functional P2X receptor in mouse cortical astrocytes. J. Neurosci. 2008, 28:5473-5480.
143. Lee E.O., Shin Y.J., Chong Y.H. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: possible involvement of multiple signal transduction and beta-catenin/T-cell factor. J. Neuroimmunol. 2004, 155:21-31.
144. Lees A.J. The Parkinson chimera. Neurology 2009, 72:S2-11.
145. Lee S.H., Magge S., Spencer D.D., Sontheimer H., Cornell-Bell A.H. Human epileptic astrocytes exhibit increased gap junction coupling. Glia 1995, 15:195-202.
146. Lee S.Y., Haydon P.G. Astrocytic glutamate targets NMDA receptors. J. Physiol. 2007, 581:887-888.
147. Lenhossek M.v. Der feinere Bau des Nervensystems im Lichte neuester Forschung 1893, Fischer's Medicinische Buchhandlung H. Kornfield, Berlin.
148. Leoni G., Rattray M., Butt A.M. NG2 cells differentiate into astrocytes in cerebellar slices. Mol. Cell Neurosci. 2009, 42:208-218.
149. Levine J.M., Beasley L., Stallcup W.B. Localization of a neurectoderm-associated cell surface antigen in the developing and adult rat. Brain Res. 1986, 392:211-222.
150. Liang X.B., Wang Q., Hand T., Wu L.J., Breyer R.M., Montine T.J., Andreasson K. Deletion of the prostaglandin E-2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J. Neurosci. 2005, 25:10180-10187.
151. Liauw J., Hoang S., Choi M., Eroglu C., Sun G.H., Percy M., Wildman-Tobriner B., Bliss T., Guzman R.G., Barres B.A., Steinberg G.K. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J. Cereb. Blood Flow. Metab. 2008, 28:1722-1732.
152. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 1999, 5:1403-1409.
153. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Stahlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:468-481.
154. Lindberg C., Selenica M.L.B., Westlind-Danielsson A., Schultzberg M. β-Amyloid protein structure determines the nature of cytokine release from rat microglia. J. Mol. Neurosci. 2005, 27:1-12.
155. Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 2002, 22:4825-4832.
156. Lin S.C., Bergles D.E. Physiological characteristics of NG2-expressing glial cells. J. Neurocytol. 2002, 31:537-549.
157. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003, 304:1-7.
158. Lotz M., Ebert S., Esselmann H., Iliev A.I., Prinz M., Wiazewicz N., Wiltfang J., Gerber J., Nau R. Amyloid β peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. J. Neurochem. 2005, 94:289-298.
159. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy G.M., Brachova L., Yan S.D., Walker D.G., Shen Y., Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 2001, 35:72-79.
160. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 2006, 209:2304-2311.
161. Magistretti P.J. Role of glutamate in neuron-glia metabolic coupling. Am. J. Clin. Nutr. 2009, 90:875S-880S.
162. Manning T.J., Sontheimer H. Spontaneous intracellular calcium oscillations in cortical astrocytes from a patient with intractable childhood epilepsy (Rasmussen's encephalitis). Glia 1997, 21:332-337.
163. Martinez-Hernandez A., Bell K.P., Norenberg M.D. Glutamine synthetase: glial localization in brain. Science 1977, 195:1356-1358.
164. Matos M., Augusto E., Oliveira C.R., Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 2008, 156:898-910.
165. 7 receptors in oligodendrocytes: a novel target for neuroprotection. Mol. Neurobiol. 2008, 38:123-128.
166. Matute C., Alberdi E., Domercq M., Sanchez-Gomez M.V., Perez-Samartin A., Rodriguez-Antiguedad A., Perez-Cerda F. Excitotoxic damage to white matter. J. Anat. 2007, 210:693-702.
167. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 2004, 24:257-268.
168. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001, 357:436-439.
169. McGeer E.G., McGeer P.L. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 1999, 5:821-836.
170. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
171. McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:459-470.
172. McGeer P.L., McGeer E.G. The possible role of complement activation in Alzheimer disease. Trends Mol. Med. 2002, 8:519-523.
173. McGeer P.L., McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord. 2008, 23:474-483.
174. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
175. 25-35. J. Neuroimmunol. 1999, 93:45-52.
176. Mena M.A., de Yebenes J.G. Drug-induced parkinsonism. Expert. Opin. Drug Saf. 2006, 5:759-771.
177. Mena M.A., Garcia de Yebenes J. Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia. Neuroscientist 2008, 14:544-560.
178. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., Garcia de Yebenes J. Glia conditioned medium protects fetal rat midbrain neurones in culture from l-DOPA toxicity. Neuroreport 1996, 7:441-445.
179. Mena M.A., Casarejos M.J., Garcia de Yebenes J. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity. J. Neural. Transm. 1999, 106:1105-1123.
180. Mena M.A., de Bernardo S., Casarejos M.J., Canals S., Rodriguez-Martin E. The role of astroglia on the survival of dopamine neurons. Mol. Neurobiol. 2002, 25:245-263.
181. Metea M.R., Newman E.A. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J. Neurosci. 2006, 26:2862-2870.
182. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., Hyman B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
183. Minghetti L., Polazzi E., Nicolini A., Creminon C., Levi G. Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur. J. Neurosci. 1997, 9:934-940.
184. Mrak R.E., Griffin W.S. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 2001, 22:903-908.
185. Mulligan S.J., MacVicar B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004, 431:195-199.
186. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007, 10:615-622.
187. Nagatsu T., Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Design 2005, 11:999-1016.
188. Nagele R.G., D'Andrea M.R., Lee H., Venkataraman V., Wang H.Y. Astrocytes accumulate A β 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003, 971:197-209.
189. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., Wang K.C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging 2004, 25:663-674.
190. Nardacci R., Antinori A., Kroemer G., Piacentini M. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia. Cell Death Differ. 2005, 12(Suppl. 1):855-858.
191. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999, 79:1193-1226.
192. Nave K.A., Sereda M.W., Ehrenreich H. Mechanisms of disease: inherited demyelinating neuropathies-from basic to clinical research. Nat. Clin. Pract. Neurol. 2007, 3:453-464.
193. Ndubaku U., de Bellard M.E. Glial cells: old cells with new twists. Acta Histochem. 2008, 110:182-195.
194. Nedergaard M., Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005, 50:281-286.
195. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003, 26:523-530.
196. Newman E.A. Glial cell regulation of extracellular potassium. Neuroglia 1995, 717-731. Oxford University Press, NY. H. Kettenmann, B. Ransom (Eds.).
197. + siphoning. Science 1984, 225:1174-1175.
198. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 2000, 47:365-368.
199. Nieweg K., Schaller H., Pfrieger F.W. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 2009, 109:125-134.
200. Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K., Onoe K. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. J. Neuroimmunol. 2001, 116:40-48.
201. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
202. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 2009, 10:9-22.
203. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., Coleman P.D. Interleukin-1 β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 1996, 66:2532-2540.
204. Oberheim N.A., Wang X., Goldman S., Nedergaard M. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 2006, 29:547-553.
205. Oberheim N.A., Takano T., Han X., He W., Lin J.H., Wang F., Xu Q., Wyatt J.D., Pilcher W., Ojemann J.G., Ransom B.R., Goldman S.A., Nedergaard M. Uniquely hominid features of adult human astrocytes. J. Neurosci. 2009, 29:3276-3287.
206. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
207. Okun E., Griffioen K.J., Lathia J.D., Tang S.C., Mattson M.P., Arumugam T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
208. Oliet S.H., Mothet J.P. Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine. Neuroscience 2009, 158:275-283.
209. Owe S.G., Marcaggi P., Attwell D. The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia. J. Physiol. 2006, 577:591-599.
210. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., Oliet S.H. Glia-derived d-serine controls NMDA receptor activity and synaptic memory. Cell 2006, 125:775-784.
211. Pankratov Y., Lalo U., Verkhratsky A., North R.A. Vesicular release of ATP at central synapses. Pflugers Arch. 2006, 452:589-597.
212. Papassotiropoulos A., Bagli M., Jessen F., Bayer T.A., Maier W., Rao M.L., Heun R. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 1999, 45:666-668.
213. Parkinson J. An Essay on the Shaking Palsy 1817, 66. Sherwood, Neely, and Jones, London.
214. Parkinson J. An essay on the shaking palsy. 1817. J. Neuropsychiatry Clin. Neurosci. 2002, 14:223-236.
215. Parpura V., Haydon P.G. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8629-8634.
216. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y., Takano H., Moss S.J., McCarthy K., Haydon P.G. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005, 310:113-116.
217. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
218. Pellerin L., Bouzier-Sore A.K., Aubert A., Serres S., Merle M., Costalat R., Magistretti P.J. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 2007, 55:1251-1262.
219. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 2009, 32:421-431.
220. Perry R.T., Collins J.S., Wiener H., Acton R., Go R.C. The role of TNF and its receptors in Alzheimer's disease. Neurobiol. Aging 2001, 22:873-883.
221. Pfrieger F.W. Roles of glial cells in synapse development. Cell Mol. Life Sci. 2009, 66:2037-2047.
222. Pfrieger F.W., Barres B.A. New views on synapse-glia interactions. Curr. Opin. Neurobiol. 1996, 6:615-621.
223. Phul R.K., Shaw P.J., Ince P.G., Smith M.E. Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000, 1:259-267.
224. Polazzi E., Altamira L.E.P., Eleuteri S., Barbaro R., Casadio C., Contestabile A., Monti B. Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor β-2. J. Neurochem. 2009, 110:545-556.
225. Pompl P.N., Ho L., Bianchi M., McManus T., Qin W., Pasinetti G.M. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2003, 17:725-727.
226. Potts R., Leech R.W. Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. Clin. Neuropathol. 2005, 24:271-275.
227. Pramatarova A., Laganiere J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 2001, 21:3369-3374.
228. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 1998, 273:32730-32738.
229. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45:1085-1098.
230. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
231. Ransom B., Behar T., Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci. 2003, 26:520-522.
232. Retzius G. Biol Untersuchungen. Die neuroglia des Gehirns beim Menschen und bei Saeugethieren 1894-1916, 1-28.
233. Rio-Hortega P.d. El tercer elemento de los centros nerviosos. I. La microglia en estado normal. II. Intervencíon de la microglia en los procesos patológicos. III. Naturaleza probable de la microglia. Bol de la Soc esp de biol 1919, 9:69-120.
234. Rio-Hortega P.d. Poder fagocitario y movilidad de la microglia. Bol de la Soc esp de biol 1919, 9:154.
235. Rio-Hortega P.d. La microglia y su transformacíon en células en bastoncito y cuerpos gránulo-adiposos. Trab del Lab de invest biol 1920, 18:37.
236. Rio-Hortega P.d. Estudios sobre la neuroglia. La glia de escasa radiaciones oligodendroglia. Bol, Soc, Esp, Biol. 1921, 21:64-92.
237. Rodriguez J.J., Olabarria M., Chvatal A., Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 2009, 16:378-385.
238. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:235-241.
239. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
240. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 2009, 80:224-232.
241. Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008, 15:1691-1700.
242. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
243. Rossi F., Bianchini E. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 1996, 225:474-478.
244. Rossner S., Lange-Dohna C., Zeitschel U., Perez-Polo J.R. Alzheimer's disease β-secretase BACE1 is not a neuron-specific enzyme. J. Neurochem. 2005, 92:226-234.
245. Rota E., Bellone G., Rocca P., Bergamasco B., Emanuelli G., Ferrero P. Increased intrathecal TGF-β 1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer's disease patients. Neurol. Sciences 2006, 27:33-39.
246. Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555.
247. Roy C.S., Sherrington C.S. On the regulation of the blood-supply of the brain. J. Physiol. (Lond) 1890, 11:85-108.
248. 7 receptor expression. J. Immunol. 2009, 182:4378-4385.
249. Sastre M., Dewachter I., Landreth G.E., Willson T.M., Klockgether T., Van Leuven F., Heneka M.T. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J. Neurosci. 2003, 23:9796-9804.
250. Sastre M., Dewachter I., Rossner S., Bogdanovic N., Rosen E., Borghgraef P., Evert B.O., Dumitrescu-Ozimek L., Thal D.R., Landreth G., Walter J., Klockgether T., Van Leuven F., Heneka M.T. Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPAR γ. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:443-448.
251. Scemes E., Giaume C. Astrocyte calcium waves: what they are and what they do. Glia 2006, 54:716-725.
252. Schleich C.L. Schmerzlose Operationen: Örtliche Betäubung mit indiffrenten Flüssigkeiten. Psychophysik des natürlichen und künstlichen Schlafes 1894, 256. Julius Springer, Berlin.
253. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C., Ferroni S. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann. N.Y. Acad. Sci. 2000, 903:24-33.
254. Schutz B., Reimann J., Dumitrescu-Ozimek L., Kappes-Horn K., Landreth G.E., Schurmann B., Zimmer A., Heneka M.T. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 2005, 25:7805-7812.
255. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
256. Selmaj K.W., Farooq M., Norton W.T., Raine C.S., Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 1990, 144:129-135.
257. Shie F.S., Breyer R.M., Montine T.J. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity. Am. J. Pathol. 2005, 166:1163-1172.
258. Shie F.S., Montine K.S., Breyer R.M., Montine T.J. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia 2005, 52:70-77.
259. Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
260. Slawik H., Volk B., Fiebich B., Hull M. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum. Neurochem. Int. 2004, 45:653-660.
261. Smith K.J., Hall S.M. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr. Opin. Neurol. 2001, 14:289-298.
262. Stallcup W.B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 2002, 31:423-435.
263. Standaert D.G., Theodore S., Cao S.W., McLean P. α-Synuclein triggers microglial activation and adaptive immunity in a mouse model of Parkinson disease. Neurology 2009, 72:A438.
264. Swanson R.A. Astrocyte neurotransmitter uptake. Neuroglia 2005, 346-354. Oxford University Press, Oxford. H. Kettenmann, B. Ransom (Eds.).
265. Szczepanik A.M., Rampe D., Ringheim G.E. Amyloid-β peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J. Neurochem. 2001, 77:304-317.
266. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
267. Takadera T., Shiraishi Y., Ohyashiki T. Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons. Neurochem. Int. 2004, 45:713-719.
268. Takano T., Tian G.F., Peng W., Lou N., Libionka W., Han X., Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 2006, 9:260-267.
269. Talbot K. Motor neurone disease. Postgrad. Med. J. 2002, 78:513-519.
270. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
271. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
272. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 2000, 192:359-366.
273. Theodore S., Cao S.W., McLean P., Standaert D. Microglial activation and adaptive immune response in a mouse model of Parkinson's disease. J. Neuroimmunol. 2008, 203:188-189.
274. Thery C., Stanley E.R., Mallat M. Interleukin-1 and tumor-necrosis-factor-α stimulate the production of colony-stimulating factor-I by murine astrocytes. J. Neurochem. 1992, 59:1183-1186.
275. Thompson K.A., McArthur J.C., Wesselingh S.L. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 2001, 49:745-752.
276. Tian G.F., Azmi H., Takano T., Xu Q., Peng W., Lin J., Oberheim N., Lou N., Wang X., Zielke H.R., Kang J., Nedergaard M. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
277. Toggas S.M., Masliah E., Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain. Res. 1996, 706:303-307.
278. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
279. Tsai G., Yang P., Chung L.C., Lange N., Coyle J.T. d-Serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 1998, 44:1081-1089.
280. Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell. Biol. 2005, 37:289-305.
281. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008, 85:94-134.
282. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [C-11](R)-PK11195 positron emission tomography study 1. Neurobiol. Dis. 2004, 15:601-609.
283. van Beek J., Elward K., Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N.Y. Acad. Sci. 2003, 992:56-71.
284. van der Valk P., Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 2009, 22:207-213.
285. van Swieten J.C., Caplan L.R. Binswanger's disease. Adv. Neurol. 1993, 62:193-211.
286. Vanzani M.C., Iacono R.F., Caccuri R.L., Troncoso A.R., Berria M.I. Regional differences in astrocyte activation in HIV-associated dementia. Medicina (B Aires) 2006, 66:108-112.
287. Veerhuis R., Boshuizen R.S., Morbin M., Mazzoleni G., Hoozemans J.J.M., Langedijk J.P.M., Tagliavini F., Langeveld J.P.M., Eikelenboom P. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q. Neurobiol. Dis. 2005, 19:273-282.
288. Verkhratsky A. Calcium ions and integration in neural circuits. Acta Physiol. (Oxf) 2006, 187:357-369.
289. Verkhratsky A. Patching the glia reveals the functional organisation of the brain. Pflugers. Arch. 2006, 453:411-420.
290. Verkhratsky A. Neuronismo y reticulismo: neuronal-glial circuits unify the reticular and neuronal theories of brain organization. Acta Physiol. (Oxf) 2009, 195:111-122.
291. Verkhratsky A., Butt A. Glial Neurobiology. A Textbook 2007, John Wiley & Sons, Chichester.
292. Verkhratsky A., Kettenmann H. Calcium signalling in glial cells. Trends Neurosci. 1996, 19:346-352.
293. Verkhratsky A., Kirchhoff F. Glutamate-mediated neuronal-glial transmission. J. Anat. 2007, 210:651-660.
294. Verkhratsky A., Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007, 13:28-37.
295. Verkhratsky A., Steinhauser C. Ion channels in glial cells. Brain Res. Brain Res. Rev. 2000, 32:380-412.
296. Verkhratsky A., Toescu E.C. Neuronal-glial networks as substrate for CNS integration. J. Cell. Mol. Med. 2006, 10:826-836.
297. Verkhratsky A., Orkand R.K., Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol. Rev. 1998, 78:99-141.
298. Verkhratsky A., Krishtal O.A., Burnstock G. Purinoceptors on neuroglia. Mol. Neurobiol. 2009, 39:190-208.
299. Virchow R. Gesammelte Abhandlungen zyr wissenschaftlischen Medizin 1856, Verlag von Meidinger Sohn & Comp, Frankfurt.
300. Virchow R. Die Cellularpathologie in ihrer Begründung auf physiologische and pathologische Gewebelehre. Zwanzig Vorlesungen gehalten während der Monate Februar, März und April 1858 im pathologischen Institut zu Berlin 1858, 440. August Hirschwald, Berlin.
301. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
302. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., Bode B., Manietta N., Walter J., Schulz-Schuffer W., Fassbender K. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 2007, 20:947-956.
303. Warr O., Takahashi M., Attwell D. Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange. J. Physiol. 1999, 514:783-793.
304. Webster S., Lue L.F., Brachova L., Tenner A.J., McGeer P.L., Terai K., Walker D.G., Bradt B., Cooper N.R., Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging 1997, 18:415-421.
305. Weigert K. Beiträge zur Kenntnis der normalen menschlichen Neuroglia 1895, Frankfurt, Diesterweg.
306. Wernicke C. Lehrbuch der Gehirnkrankheiten für Aerzte und Studirende 1881-1883, Fischer, Kassel und Berlin.
307. Wilhelmsson U., Bushong E.A., Price D.L., Smarr B.L., Phung V., Terada M., Ellisman M.H., Pekny M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17513-17518.
308. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432.
309. Wyss-Coray T., Lin C., Sanan D.A., Mucke L., Masliah E. Chronic overproduction of transforming growth factor-β 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 2000, 156:139-150.
310. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., Husemann J. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat. Med. 2003, 9:453-457.
311. Xia M.Q., Hyman B.T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 1999, 5:32-41.
312. Xia M.Q., Qin S.X., Wu L.J., Mackay C.R., Hyman B.T. Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 1998, 153:31-37.
313. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
314. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res. 1999, 830:226-236.
315. Yasojima K., Tourtellotte W.W., McGeer E.G., McGeer P.L. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 2001, 57:952-956.
316. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 2002, 80:158-167.
317. Zerangue N., Kavanaugh M.P. Flux coupling in a neuronal glutamate transporter. Nature 1996, 383:634-637.
318. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M.W., Sarang S., Liu A.S., Hartley D.M., Du C.W., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.
319. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.A., Pozzan T., Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 2003, 6:43-50.